Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant

ClinicalTrials.gov ID: NCT00114777

Public ClinicalTrials.gov record NCT00114777. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial - Extended Criteria Donors (BENEFIT-EXT)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to learn if Belatacept is effective and safe as a first line of immunosuppression treatment in patients undergoing a renal transplant where the donor kidney is obtained in patients with extended criteria.

Study identification

NCT ID
NCT00114777
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
595 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2005
Primary completion
Apr 30, 2008
Completion
Aug 31, 2014
Last update posted
Jul 6, 2017

2005 – 2014

United States locations

U.S. sites
28
U.S. states
17
U.S. cities
23
Facility City State ZIP Site status
University Of Alabama At Birmingham Birmingham Alabama 35294
Ucla Kidney & Kidney-Pancreas Transplant Research Office Los Angeles California 90024
National Institute Of Transplantation Los Angeles California 90057
Sharp Memorial Hospital San Diego California 92133
University Of California San Francisco Medical Center San Francisco California 94143
University Of Colorado Health Sciences Center Aurora Colorado 80045
Yale University School Of Medicine New Haven Connecticut 06540
Lifelink Healthcare Institute Tampa Florida 33606
Piedmont Transplant Institute Atlanta Georgia 30309
Emory University Hospital Atlanta Georgia 30322
Northwestern University-Feinberg School Of Medicine Chicago Illinois 60611
University Of Chicago Hospitals Chicago Illinois 60637
Acadiana Renal Physicians New Iberia Louisiana 70563
Tulane Abdominal Transplant Institute New Orleans Louisiana 70112
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Western New England Renal & Transplant Associates, Pc Springfield Massachusetts 01107
Henry Ford Hospital, Transplant Institute Detroit Michigan 48202
University Of Minnesota Minneapolis Minnesota 55455
Washington University School Of Medicine St Louis Missouri 63110
Mount Sinai School Of Medicine New York New York 10029
Columbia University College Of Physicians & Surgeons New York New York 10032
University Of North Carolina At Chapel Hill Chapel Hill North Carolina 27599
Carolinas Medical Center Charlotte North Carolina 28203
Drexel University College Of Medicine, Department Of Surgery Philadelphia Pennsylvania 19102
University Of Pennsylvania Philadelphia Pennsylvania 19104
Baylor University Medical Center Dallas Texas 75246
University Of Wisconsin Madison Wisconsin 53792
Froedtert Memorial Hospital Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00114777, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 6, 2017 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00114777 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →